ASKA Biotech GmbH

Name ›

Address/P.O. Box › Postal Code/City › Country › Contact Person › Telephone › Email › Website › Social Media › Number of Employees › Founded (year) › Type of Laboratory ›

Areas of Activity ›

Altasciences

575 Armand-Frappier Blvd. Laval, QC H7V 4B3 Canada Sophie Dubois +1-450-973-6077 contact@altasciences.com https://www.altasciences.com/

I 

+1,800 1992 Full-service CRO/CDMO offering comprehensive range of preclinical, clinical, bioanalytical, and CDMO services.

Preclinical safety testing, clinical pharmacology and proof of concept, bioanalysis, drug formulation and manufacturing, programme management, medical writing, biostatistics, and data management.

European Biotechnology

What We Do

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions to offer pharmaceutical and biotechnology companies a proven, integrated approach to preclinical and clinical pharmacology studies, including bioanalysis, formulation, manufacturing, and analytical services. Our comprehensive, full-service solutions are customisable to specific sponsor requirements. With eight locations across North America, Altasciences helps sponsors get better drugs to the people who need them, faster.

Who We Are

For over 25 years, our Altascientists have been partnering with drug sponsors to design the most efficient preclinical, clinical, bioanalytical, or manufacturing programmes that meet all regulatory requirements. We are committed to ensuring timely information capture, proactive communication, and smooth transitions between phases and studies.

Integrated Drug Development Solutions

At Altasciences, early phase drug development is approached as a single continuum, rather than a series of separate steps. We can support your entire programme end to end, or you can partner with us for just one element — we offer complete flexibility. Our outsourcing platform enables you to work with a single, integrated partner from lead candidate selection to clinical proof of concept, and beyond. By centralising communication and scheduling using proprietary platforms as well as applying robust insights at each development stage, we help sponsors make more educated, faster, and more complete early phase drug development decisions. Our programme managers are the single point of contact for a comprehensive, full-service package designed to minimise hand-offs, resulting in shorter timelines and reduced costs. We call this Proactive Drug Development.

8

IN NORTH AMERICA

A DIFFERENT KIND OF CRO/CDMO

Our Drug Development Solutions:

Whether for one study or multiple programmes, we offer you a customised and synchronised approach to CRO and CDMO services for your regulatory submissions. Preclinical Services: › 3 facilities for a total of 550K sq. ft. › 700+ safety studies conducted annually › 500+ team members › Full range of in vivo non-GLP and GLP safety evalation studies, for large and small molecules › Experience with both rodent and non-rodent species › Multiple routes of administration Clinical Services: › 3 facilities in the United States and Canada › 500+ beds › 285+ clinical trials completed annually › 400K+ participants in our database › First-in-human to end of Phase II › Specialty trials › Healthy normal volunteers (HNVs), patients, and special populations Bioanalytical Services: › From discovery to preclinical to Phase IV › 200+ highly trained regulatory bioanalysis specialists › Capacity for 60,000+ study samples per month › 25+ research and development scientists › Small and large molecules › Mass spectrometry, ligand binding, or hybrid assays Manufacturing and Analytical Services: › Small molecules › Formulation development › Phase I through commercial manufacturing › ICH stability testing Research Support Services: › Centralised project and programme management › Scientific, regulatory, and strategic guidance for your

IND/CTA submissions › Clinical protocol development › Data management › Biostatistics › Medical writing › Clinical reporting › CDISC › Archiving